9.79
Schlusskurs vom Vortag:
$9.98
Offen:
$10.01
24-Stunden-Volumen:
659.14K
Relative Volume:
1.09
Marktkapitalisierung:
$615.40M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
10.31
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
-7.03%
1M Leistung:
-19.82%
6M Leistung:
-49.12%
1J Leistung:
-23.58%
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Vergleichen Sie EMBC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EMBC
Embecta Corp
|
9.79 | 615.40M | 1.12B | 55.30M | -30.30M | 0.95 |
![]()
ISRG
Intuitive Surgical Inc
|
557.08 | 197.97B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
173.45 | 49.82B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.79 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
252.20 | 35.89B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
BAX
Baxter International Inc
|
30.26 | 15.65B | 11.89B | -560.00M | 191.00M | -1.10 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-10 | Eingeleitet | Mizuho | Neutral |
2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2022-09-08 | Eingeleitet | BTIG Research | Neutral |
2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
InvestingPro’s bearish call on Embecta proves accurate with 48% decline By Investing.com - Investing.com Nigeria
Embecta stock hits 52-week low at $10.26 amid market challenges By Investing.com - Investing.com South Africa
Embecta stock hits 52-week low at $10.26 amid market challenges - Investing.com Australia
BofA cuts Embecta stock price target to $18 from $20 By Investing.com - Investing.com South Africa
BofA cuts Embecta stock price target to $18 from $20 - Investing.com India
(EMBC) Technical Data - news.stocktradersdaily.com
Embecta Corp (EMBC) Stock Price Down 6.22% on May 28 - GuruFocus
embecta to Participate in Investor Events - The Manila Times
embecta to Participate in Investor Events - GlobeNewswire Inc.
Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock - Yahoo Finance
Insider Buying: David Melcher Acquires 10,000 Shares of Embecta Corp (EMBC) - GuruFocus
Director Makes Bold Move with Major Stock Purchase in Embecta Corporation! - TipRanks
Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | - GuruFocus
Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | EMBC Stock News - GuruFocus
Embecta (EMBC) Price Target Cut by Mizuho Amid Flat Sales Outlook | EMBC Stock News - GuruFocus
Embecta price target lowered to $25 from $26 at BTIG - TipRanks
Embecta Corporation’s Strategic Transition and Financial Outlook: A Buy Rating Based on Growth Initiatives and Attractive Valuation - TipRanks
Embecta Corp (EMBC) Shares Gap Down to $10.85 on May 22 - GuruFocus
Embecta stock touches 52-week low at $10.82 amid market challenges - Investing.com Australia
Embecta eyes shift from insulin delivery to broader medical supplies focus - Drug Delivery Business
Transcript : Embecta Corp.Analyst/Investor Day - marketscreener.com
Embecta stock touches 52-week low at $10.82 amid market challenges By Investing.com - Investing.com South Africa
Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15 - simplywall.st
Embecta Unveils Strategy at Analyst and Investor Day - TipRanks
Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 - Yahoo Finance
Embecta Corp. Re-Affirms Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - The Manila Times
Embecta Corp. Hosts Inaugural Analyst and Investor Day to Outline Long-Term Financial Plan and Strategic Priorities - Nasdaq
embecta to Showcase Phased Approach for Value Creation and - GlobeNewswire
embecta recognized as Healthcare Technology Company of the Year - The Healthcare Technology Report.
Cautious Outlook on Embecta Corporation Amidst Unclear Growth Catalysts and Margin Concerns - TipRanks
Embecta Corp (EMBC) Shares Down 2.83% on May 19 - GuruFocus
How to Take Advantage of moves in (EMBC) - news.stocktradersdaily.com
Embecta Corp. (NASDAQ:EMBC) Q2 2025 Earnings Call Transcript - MSN
Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply (NASDAQ:EMBC) - Seeking Alpha
Embecta restructures again, outlines tariff costs - MedTech Dive
Morgan Stanley Adjusts Price Target on Embecta to $15 From $20, Maintains Equalweight Rating - marketscreener.com
Positive Outlook for Embecta Corporation Amid Strong Financial Performance and Strategic Initiatives - TipRanks
Cautious Optimism for Embecta Corporation Amid Challenging Environment and Hold Rating - TipRanks
Embecta Q2 2025 slides: Revenue decline offset by margin improvement and debt reduction - Investing.com
Earnings call transcript: Embecta Q2 2025 beats EPS forecast, stock dips - Investing.com Nigeria
Embecta Corp (EMBC) Q2 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Decline By GuruFocus - Investing.com Canada
Embecta Corporation Reports Q2 2025 Financial Results - TipRanks
Embecta earnings beat by $0.17, revenue topped estimates - Investing.com Nigeria
Embecta Corp’s Earnings Call: Progress Amid Challenges - TipRanks
Embecta to undergo further restructuring, lowers guidance amid tariff impact - MassDevice
Embecta reports Q2 adjusted EPS 70c, consensus 59c - TipRanks
Embecta Q2 2025 Earnings Call Transcript - MarketBeat
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):